Skip Nav | Home | Mobile | Editorial Guidelines | Mission Statement | About Us | Contact | Help | Security | Support Us

World

Bayer Schering: UK Primodos victims demand apology

CBGnetwork | 29.04.2010 12:00 | Education | Health | Cambridge | World

Bayer Schering: UK Primodos victims demand apology
Primodos victims appear in Bayer shareholder meeting in Cologne tomorrow

Karl Murphy from Liverpool and John Walmisley Santiago from London will speak at Bayer´s shareholder meeting in Cologne/Germany tomorrow. They will demand that the company apologizes to Primodos victims and offers a compensation scheme. Attending will be Bayer´s board, supervisory board and about 4000 shareholders.

Press Release
April 29, 2010

Bayer Schering: UK Primodos victims demand apology
Primodos victims appear in Bayer shareholder meeting in Cologne tomorrow

Karl Murphy from Liverpool and John Walmisley Santiago from London will speak at Bayer´s shareholder meeting in Cologne/Germany tomorrow. They will demand that the company apologizes to Primodos victims and offers a compensation scheme. Attending will be Bayer´s board, supervisory board and about 4000 shareholders.

Karl Murphy will say in the meeting: “Bayer have sent me a letter saying that there was no suspicion of an association between the hormones used in Primodos and any teratogenic effects. They have also said there is no association between the ingestion during pregnancy of the hormones contained in Primodos and congenital deformities alleged by myself. If Bayer are so convinced that the substances Norethisterone or Ethinlystrodiol don´t cause deformities, why put the warning on the back of each Primodos box? Why do all Bayer products which contain Norethisterone warn that a pregnant lady should not take this drug?” Murphy is the Vice Chairman of the Association of Children Damaged by Hormone Pregnancy Tests. “I ask Bayer Schering, if they are so convinced that this drug does not cause deformities, bring one of your family or employees who have just found they are pregnant and are in the first trimester of pregnancy and put them on stage and take the 2 Primodos tablets that I have from the 1970’s in front of your shareholders to show them it does not harm the baby. I know you would not do that and as I am a caring person would not give you the tablets and let you do it as I know what effects this drug would do to the unborn baby and how it would struggle through it’s life like all the victims here today who have been damaged”, Murphy adds.

John Walmisley Santiago will also adress towards the shareholders: “Many of your are parents. I know it is such a lovely experience to come home with your new baby to show to your friends and family. Even as you walk down the road, passersby will smile and look into your new pram to see the lovely new baby. But not if your child is deformed. My parents came home from hospital with a deformed child caused by an overdose of Primodos, a drug made by Schering.”

Primodos was prescribed as a hormone pregnancy test in the sixties and seventies. Several thousand children were left with deformities after their mothers took Primodos. The drug was produced by the German company Schering which was taken over by the chemical and pharmaceutical producer Bayer in 2006.

Already in 1967 the then Committee on Safety of Drugs was warned by a doctor - Dr. Isabel Gal - that foetal abnormalities were associated with the use of hormonal pregnancy testing. In the same year a new and easy method of confirming pregnancy had become available, measuring the level of hormones already present in the body by a simple urine test.

Two medical advisors from Schering Chemical Ltd in Britain were disturbed by Dr. Gal’s findings and examined the details of Primodos sales throughout the country. The Sunday Times later obtained a copy of a letter to Schering´s head office in which the advisors expressed their concern: “We must reach a decision regarding our own product Primodos and its possible relationship to foetal abnormalities. As manufacturers it is our moral duty to do all possible to ensure the safety of the preparations which we market.” The letter went on, “ethically speaking we are not satisfied that sufficient has been done to remove suspicion that has been cast upon Primodos to a sufficient degree, for us to be confident in supporting its continued availability to pregnant women in this country.”

Santiago and Murphy appear in the Bayer meeting by invitation of the Coalition against Bayer Dangers, an international network based in Germany that has been monitoring Bayer for thirty years. Both are available for interviews.

more information and the complete speeches (after the meeting): www.cbgnetwork.de/2882.html

contact Karl Murphy: 07921 262018 (mobile) or 0151 430 7899, Email  kcbm@blueyonder.co.uk
contact John Walmisley Santiago:  john.walmisleysantiago@bt.com
Coalition against Bayer Dangers:  CBGnetwork@aol.com , www.CBGnetwork.org

Coalition against BAYER Dangers (Germany)
www.CBGnetwork.org
Fax: (+49) 211-333 940 Tel: (+49) 211-333 911

Advisory Board
Prof. Juergen Junginger, designer, Krefeld,
Prof. Dr. Juergen Rochlitz, chemist, former member of the Bundestag, Burgwald
Wolfram Esche, attorney, Cologne
Dr. Sigrid Müller, pharmacologist, Bremen
Eva Bulling-Schroeter, member of the Bundestag, Berlin
Prof. Dr. Anton Schneider, biologist, Neubeuern
Dr. Janis Schmelzer, historian, Berlin
Dr. Erika Abczynski, pediatrician, Dormagen

CBGnetwork
- e-mail: CBGnetwork@aol.com
- Homepage: http://www.CBGnetwork.org

Publish

Publish your news

Do you need help with publishing?

/regional publish include --> /regional search include -->

World Topics

Afghanistan
Analysis
Animal Liberation
Anti-Nuclear
Anti-militarism
Anti-racism
Bio-technology
Climate Chaos
Culture
Ecology
Education
Energy Crisis
Fracking
Free Spaces
Gender
Globalisation
Health
History
Indymedia
Iraq
Migration
Ocean Defence
Other Press
Palestine
Policing
Public sector cuts
Repression
Social Struggles
Technology
Terror War
Workers' Movements
Zapatista

Kollektives

Birmingham
Cambridge
Liverpool
London
Oxford
Sheffield
South Coast
Wales
World

Other UK IMCs
Bristol/South West
London
Northern Indymedia
Scotland

Server Appeal Radio Page Video Page Indymedia Cinema Offline Newsheet

secure Encrypted Page

You are viewing this page using an encrypted connection. If you bookmark this page or send its address in an email you might want to use the un-encrypted address of this page.

If you recieved a warning about an untrusted root certificate please install the CAcert root certificate, for more information see the security page.

IMCs


www.indymedia.org

Projects
print
radio
satellite tv
video

Africa

Europe
antwerpen
armenia
athens
austria
barcelona
belarus
belgium
belgrade
brussels
bulgaria
calabria
croatia
cyprus
emilia-romagna
estrecho / madiaq
galiza
germany
grenoble
hungary
ireland
istanbul
italy
la plana
liege
liguria
lille
linksunten
lombardia
madrid
malta
marseille
nantes
napoli
netherlands
northern england
nottingham imc
paris/île-de-france
patras
piemonte
poland
portugal
roma
romania
russia
sardegna
scotland
sverige
switzerland
torun
toscana
ukraine
united kingdom
valencia

Latin America
argentina
bolivia
chiapas
chile
chile sur
cmi brasil
cmi sucre
colombia
ecuador
mexico
peru
puerto rico
qollasuyu
rosario
santiago
tijuana
uruguay
valparaiso
venezuela

Oceania
aotearoa
brisbane
burma
darwin
jakarta
manila
melbourne
perth
qc
sydney

South Asia
india


United States
arizona
arkansas
asheville
atlanta
Austin
binghamton
boston
buffalo
chicago
cleveland
colorado
columbus
dc
hawaii
houston
hudson mohawk
kansas city
la
madison
maine
miami
michigan
milwaukee
minneapolis/st. paul
new hampshire
new jersey
new mexico
new orleans
north carolina
north texas
nyc
oklahoma
philadelphia
pittsburgh
portland
richmond
rochester
rogue valley
saint louis
san diego
san francisco
san francisco bay area
santa barbara
santa cruz, ca
sarasota
seattle
tampa bay
united states
urbana-champaign
vermont
western mass
worcester

West Asia
Armenia
Beirut
Israel
Palestine

Topics
biotech

Process
fbi/legal updates
mailing lists
process & imc docs
tech